Measles IgG Avidity Assay.
Antibodies
Antigen
Avidity
Elimination
Immunoassay
Immunoglobulin G
Measles
Serology
Serum
Vaccine failure classification
Journal
Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969
Informations de publication
Date de publication:
2024
2024
Historique:
medline:
15
5
2024
pubmed:
15
5
2024
entrez:
14
5
2024
Statut:
ppublish
Résumé
Measles IgG avidity assays determine the overall strength of molecular binding between measles-specific IgG antibodies and measles virus antigens. Avidity results can distinguish recent from distant measles virus infections. Individuals who are immunologically naïve to measles virus develop low-avidity antibodies upon measles virus infection or first-time vaccination. Within 4-6 months, antibodies mature to high avidity. Measles avidity assays are most useful in the context of measles elimination. In such settings, avidity and epidemiological and clinical information are used to classify measles breakthrough infections for control and surveillance purposes and to assist in case confirmation when other laboratory results are inconclusive or nonexistent. We present a highly accurate end-titer measles avidity assay that delivers results based on IgG quality (avidity) that are independent of IgG concentration.
Identifiants
pubmed: 38743375
doi: 10.1007/978-1-0716-3870-5_18
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
247-264Informations de copyright
© 2024. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Eisen H, Siskind G (1964) Variation in affinities of antibodies during immune response. Biochemistry 3:996
doi: 10.1021/bi00895a027
pubmed: 14214095
Kuby J (1997) Immunology. W. H. Freeman, New York
Siskind GW, Benacerraf B (1969) Cell selection by antigen in the immune response. Adv Immunol 10:1
doi: 10.1016/S0065-2776(08)60414-9
pubmed: 4900673
El Mubarak HS, Ibrahim SA, Vos HW et al (2004) Measles virus protein-specific IgM, IgA, and IgG subclass responses during the acute and convalescent phase of infection. J Med Virol 72:290–298. https://doi.org/10.1002/jmv.10553
Mercader S, Garcia P, Bellini WJ (2012) Measles virus IgG avidity assay for use in classification of measles vaccine failure in measles elimination settings. Clin Vaccine Immunol 19:1810–1817. https://doi.org/10.1128/CVI.00406-12
Tuokko H (1995) Detection of acute measles infections by indirect and mu-capture enzyme immunoassays for immunoglobulin M antibodies and measles immunoglobulin G antibody avidity enzyme immunoassay. J Med Virol 45:306–311. https://doi.org/10.1002/jmv.1890450312
De Souza VA, Pannuti CS, Sumita LM et al (1997) Enzyme-linked immunosorbent assay-IgG antibody avidity test for single sample serologic evaluation of measles vaccines. J Med Virol 52:275–279
doi: 10.1002/(SICI)1096-9071(199707)52:3<275::AID-JMV7>3.0.CO;2-#
pubmed: 9210036
Hedman K, Lappalainen M, Seppaia I et al (1989) Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis 159:736–740. https://doi.org/10.1093/infdis/159.4.736
Hedman K, Lappalainen M, Söderlund M et al (1993) Avidity of IgG in serodiagnosis of infectious diseases. Rev Med Microbiol 4:123–129
doi: 10.1097/00013542-199307000-00001
Mercader S, Mcgrew M, Sowers SB et al (2018) Development and use of an endpoint titration assay to characterize mumps IgG avidity following measles, mumps, and rubella vaccination and wild-type mumps infection. mSphere 3(5):e00320-18. https://doi.org/10.1128/msphere.00320-18
Narita M, Yamada S, Matsuzono Y et al (1996) Immunoglobulin G avidity testing in serum and cerebrospinal fluid for analysis of measles virus infection. Clin Diagn Lab Immunol 3:211–215. https://doi.org/10.1128/cdli.3.2.211-215.1996
Thomas HI, Barrett E, Hesketh LM et al (1999) Simultaneous IgM reactivity by EIA against more than one virus in measles, parvovirus B19 and rubella infection. J Clin Virol 14:107–118. https://doi.org/10.1016/S1386-6532(99)00051-7
Nair N, Gans H, Lew-Yasukawa L et al (2007) Age-dependent differences in IgG isotype and avidity induced by measles vaccine received during the first year of life. J Infect Dis 196:1339–1345. https://doi.org/10.1086/522519
Pannuti CS, Morello RJ, Moraes JC et al (2004) Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 Sao Paulo epidemic. Clin Diagn Lab Immunol 11:119–122. https://doi.org/10.1128/cdli.11.1.119-122.2004
Paunio M, Hedman K, Davidkin I et al (2003) IgG avidity to distinguish secondary from primary measles vaccination failures: prospects for a more effective global measles elimination strategy. Expert Opin Pharmacother 4:1215–1225. https://doi.org/10.1517/14656566.4.8.1215
Atrasheuskaya AV, Blatun EM, Neverov AA et al (2005) Measles in Minsk, Belarus, 2001-2003: clinical, virological and serological parameters. J Clin Virol 34:179–185. https://doi.org/10.1016/j.jcv.2004.11.024
Bianchi S, Gori M, Fappani C et al (2022) Characterization of vaccine breakthrough cases during measles outbreaks in Milan and surrounding areas, Italy, 2017-2021. Viruses 14(5):1068. https://doi.org/10.3390/v14051068
Hamkar R, Mahmoodi M, Nategh R et al (2006) Distinguishing between primary measles infection and vaccine failure reinfection by IgG avidity assay. East Mediterr Health J 12:775–782
pubmed: 17333822
Iwamoto M, Hickman CJ, Colley H et al (2021) Measles infection in persons with secondary vaccine failure, New York City, 2018-19. Vaccine 39:5346–5350. https://doi.org/10.1016/j.vaccine.2021.07.078
Kurata T, Yamamoto SP, Nishimura H et al (2021) A measles outbreak in Kansai International Airport, Japan, 2016: analysis of the quantitative difference and infectivity of measles virus between patients who are immunologically naive versus those with secondary vaccine failure. J Med Virol 93:3446–3454. https://doi.org/10.1002/jmv.26733
Mercader S, Dominguez A, Torner N et al (2021) Classification of measles breakthrough cases in an elimination setting using a comprehensive algorithm of laboratory results: why sensitive and specific IgM assays are important. Int J Infect Dis 112:21–24. https://doi.org/10.1016/j.ijid.2021.09.004
Hickman CJ, Hyde TB, Sowers SB et al (2011) Laboratory characterization of measles virus infection in previously vaccinated and unvaccinated individuals. J Infect Dis 204(Suppl 1):S549–S558. https://doi.org/10.1093/infdis/jir106
Rota JS, Hickman CJ, Sowers SB et al (2011) Two case studies of modified measles in vaccinated physicians exposed to primary measles cases: high risk of infection but low risk of transmission. J Infect Dis 204(Suppl 1):S559–S563. https://doi.org/10.1093/infdis/jir098
Sowers SB, Rota JS, Hickman CJ et al (2016) High concentrations of measles neutralizing antibodies and high-avidity measles IgG accurately identify measles reinfection cases. Clin Vaccine Immunol 23:707–716. https://doi.org/10.1128/CVI.00268-16
Venkat H, Briggs G, Brady S et al (2019) Measles outbreak at a privately operated detention facility: Arizona, 2016. Clin Infect Dis 68:2018–2025. https://doi.org/10.1093/cid/ciy819
Brunell PA, Vimal V, Sandu M et al (1995) Abnormalities of measles antibody response in human immunodeficiency virus type 1 (HIV-1) infection. J Acquir Immune Defic Syndr Hum Retrovirol 10:540–548
doi: 10.1097/00042560-199510050-00007
pubmed: 8548333
Song MK, Vindurampulle CJ, Capozzo AV et al (2005) Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins. J Virol 79:9854–9861. https://doi.org/10.1128/jvi.79.15.9854-9861.2005
Spoulou V, Giannaki M, Vounatsou M et al (2004) Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants. Bone Marrow Transplant 33:1187–1190. https://doi.org/10.1038/sj.bmt.1704476
Zlamy M, Zoggeler T, Bachmann M et al (2022) Immunological memory and affinity maturation after vaccination in patients with propionic acidemia. Front Immunol 13:774503. https://doi.org/10.3389/fimmu.2022.774503
Jenum PA, Stray-Pedersen B, Gundersen AG (1997) Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity. J Clin Microbiol 35:1972–1977. https://doi.org/10.1128/jcm.35.8.1972-1977.1997